Quick Links

 Selected Publications

Kahn D, Menda Y, Kernstine KH, Bushnell D, McLaughlin K, Miller S, Berbaum K.  The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomorgraphy and surgical staging in patients with suspected non-small cell lung cancer.  Chest 125:494-501, 2004.

Detterbeck F, Jones D, Kernstine KH, Naunheim K.  Special Treatment Issues. Chest  123:244S-258S, 2003.  

Campos JH, Kernstine KH.  Is There a Better Endotracheal Tube for Lung Isolation?  A  comparison of three endotracheal tubes:  A Left-Sided Double Lumen Endotracheal Tube Broncho-Cath, a Single-Lumen Endotracheal Tube with enclosed bronchial blocker (Torque Control Blocker) and the Wire Guided Endobronchial Blocker (Arndt).  Anesth Analg: 96, SCA26:2003. 
     
Campos JH, Kernstine KH.  Use of the Wire-Guided Endobronchial Blocker In Isolated Upper and Lower Airway Abnormalities.  J Cardiothorac Vasc Anesth, 17:352-354;2003.             
     
Campos JH, Kernstine KH.  A Structural Complication in the Torque Control Blocker Univent:®: Fracture of the Blocker Cap Connector.   Anesth Analg 96:630-631;2003.

Kernstine KH, McLaughlin KA, Menda Y, Rossi NP, Kahn DJ, Bushnell DL, Graham MM, Brown CK, Madsen MT.  Can FDG-PET Reduce the Need for Mediastinoscopy in Potentially Resectable Non-Small Cell Lung Cancer?  Ann Thorac Surg, 2002;73:394-402.

Croft DR, Trapp J, Kernstine KH, Kirchner P, Mullan BF, Galvin JR, Peterson MW, Gross T, McLennan G, Kern JA.  FDG-PET imaging and the diagnosis of non-small lung cancer in a region of high histoplasmosis prevalence.  Lung Cancer 36: 297-301, June 2002.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.

 Search

Go!
Advanced Search Options
News & Publications Search
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Read more here...
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.